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Abstract
Introduction: There has been insufficient attention to long-term care and treatment for pregnant women diagnosed with
HIV.
Objective and Methods: This prospective cohort study of 100 HIV-positive women recruited within pregnancy-related
services in a district hospital in Kenya employed quantitative methods to assess attrition between women testing HIV-
positive in pregnancy-related services and accessing long-term HIV care and treatment services. Qualitative methods were
used to explore barriers and facilitators to navigating these services. Structured questionnaires were administered to
cohort participants at enrolment and 90+ days later. Participants’ medical records were monitored prospectively. Semi-
structured qualitative interviews were carried out with a sub-set of 19 participants.
Findings: Only 53/100 (53%) women registered at an HIV clinic within 90 days of HIV diagnosis, of whom 27/53 (51%) had a
CD4 count result in their file. 11/27 (41%) women were eligible for immediate antiretroviral therapy (ART); only 6/11 (55%)
started ART during study follow-up. In multivariable logistic regression analysis, factors associated with registration at the
HIV clinic within 90 days of HIV diagnosis were: having cared for someone with HIV (aOR:3.67(95%CI:1.22, 11.09)), not having
to pay for transport to the hospital (aOR:2.73(95%CI:1.09, 6.84)), and having received enough information to decide to have
an HIV test (aOR:3.61(95%CI:0.83, 15.71)). Qualitative data revealed multiple factors underlying high patient drop-out related
to women’s social support networks (e.g. partner’s attitude to HIV status), interactions with health workers (e.g. being given
unclear/incorrect HIV-related information) and health services characteristics (e.g. restricted opening hours, long waiting
times).
Conclusion: HIV testing within pregnancy-related services is an important entry point to HIV care and treatment services,
but few women successfully completed the steps needed for assessment of their treatment needs within three months of
diagnosis. Programmatic recommendations include simplified pathways to care, better-tailored counselling, integration of
ART into antenatal services, and facilitation of social support.
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Introduction
Global attention to HIV testing in pregnancy has focused
almost exclusively on prevention of mother-to-child transmission
(PMTCT) of HIV. [1] Attention is now increasingly being paid to
linking women who are diagnosed with HIV in antenatal or
delivery services (collectively ‘‘pregnancy-related services’’) to long-
term care and treatment for their own HIV infection. [2].
Based on the potential advantages to mother and infant of early
initiation of maternal antiretroviral therapy (ART), [3] Kenya,
along with many other countries, is considering the adoption of a
policy of immediate lifelong ART for all women diagnosed with
HIV during pregnancy (also known as ‘‘Option B+’’). To
maximize the potential benefits of Option B+, linkage into ART
services following an HIV diagnosis in pregnancy-related services
is required. However, a recent systematic literature review
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highlighted sub-optimal linkage into long-term HIV care and
treatment services of women diagnosed with HIV during
pregnancy. [4].
We carried out a retrospective cohort study in Naivasha
Hospital, Kenya, between January 2008 and June 2010, finding
high attrition along the pathway to HIV care and treatment:
within six months of diagnosis with HIV in pregnancy-related
services, only 153/892 (17%) women had registered at the on-site
HIV clinic. Of 99 women with a recorded CD4 count, 53 were
eligible for and only 21 (40%) initiated ART within six months of
HIV diagnosis. [5] This review was based on manually-matched
hospital records, potentially underestimating uptake of care in
nearby health facilities.
We therefore recruited a cohort of HIV-positive women within
pregnancy-related services in the same hospital and followed them
prospectively, aiming to quantify uptake of long-term HIV care
and treatment services while taking into account uptake of services
at other nearby health facilities and to explore reasons underlying
client attrition along the care continuum.
Methods
Ethics Statement
Ethical approval was provided by the University of Nairobi/
Kenyatta National Hospital Ethics Review Committee and the
London School of Hygiene & Tropical Medicine Ethics Commit-
tee. Information sheets were read to all participants and written
informed consent was obtained at enrolment and again for
qualitative interviews. This included consent for researchers to
access participants’ medical records. Three women aged 16–17
participated, each of whom was deemed competent to provide
informed consent; involvement of their parents was discussed and
encouraged but refused by the participants. To preserve confi-
dentiality, unique study numbers were assigned at enrolment and
used in all active databases and documents. After the qualitative
interviews, participants who were not engaged with HIV care were
encouraged to attend clinic.
Setting
This study was carried out in Naivasha District Hospital, Rift
Valley Province, Kenya. Among women in Rift Valley Province,
HIV prevalence is 6.3%, [6] while in the study hospital the
estimated HIV prevalence of HIV among antenatal attendees is
4% (based on routine hospital data, 2009–10).
According to Kenyan national guidelines at the time of the
study, pregnant women with unknown HIV status should have
been offered provider-initiated rapid HIV testing and counselling.
[7] Women who tested HIV-positive should have been given
nevirapine (an intra-partum dose for themselves and a post-natal
course for their infant). Lifelong ART, provided free, was
recommended for pregnant women with a CD4 count #350
cells/mm3 and could be initiated within two days of diagnosis.
[7,8].
Naivasha Hospital policy at the time stated that, immediately
following diagnosis with HIV in antenatal care (ANC), women
should have been accompanied by the ANC nurse to the on-site
HIV clinic for clinical staging, a two-week prescription of
antenatal zidovudine (AZT) and cotrimoxazole, and referral to
the on-site laboratory for CD4 count testing and then on to the
pharmacy to collect their medications. Upon registration clients
were asked to return within one week for a CD4 count test and
then again two weeks later for the test result.
Enrolment and Follow-up
Cohort study. Between January and September 2010, a
consecutive sample of all women diagnosed with HIV who
reported having been previously unaware of their HIV status and
were $15 years attending Naivasha Hospital pregnancy-related
services were invited to join the study cohort. Enrolment into the
cohort took place on the same day that women were found to be
eligible i.e. either on the day of their HIV diagnosis or during a
repeat visit to pregnancy-related services.
Face-to-face questionnaires were administered to women at
enrolment covering the woman’s pregnancy history, experience of
HIV illness, testing and care, knowledge and attitudes about HIV
care and treatment, and social support. For participants recruited
within ANC, research staff were asked to escort study participants
to the HIV clinic immediately following their study enrolment.
A follow-up questionnaire was administered by telephone or in
person at least three months following enrolment to elicit
information from women on pregnancy-related and HIV services
accessed since diagnosis, disclosure and levels of social support,
and recent illness.
In addition, researchers searched the registration books for
attendance by participants at Naivasha Hospital and five
additional HIV clinics where women were most often referred
for care.
Attrition at each step along the pathway to HIV care and
treatment was assessed using health facility records. Univariable
logistic regression analysis was used to assess which factors were
associated with registration at an HIV clinic within 90 days of HIV
diagnosis. All variables associated with the outcome (p,0.10) were
included in a multivariable logistic regression model, except for
‘personally knowing someone with HIV’, which was excluded due
to colinearity with ‘personally knowing someone who has died
from AIDS’.
Quantitative data were double-entered into Epi-Data Version
3.1 and any errors resolved. Analysis used Stata 10.1 (Stata Corp,
College Station, Texas).
Qualitative sub-study. Face-to-face semi-structured qualita-
tive interviews were carried out to explore the factors affecting
women’s access to HIV-related services. Attempts were made to
contact 38 cohort participants for an interview, of whom half
(n = 19) were interviewed. Initially participants with no/low
attendance at the HIV clinic were selected but due to difficulties
contacting and arranging face-to-face interviews with women with
low attendance, the sampling strategy was broadened to also
include women with higher HIV clinic attendance.
Interviews lasted 40–90 minutes. Domains of inquiry included:
living situation, experience of HIV diagnosis, social support,
experiences of discrimination, and health-seeking behaviours.
Reasons given by participants for not attending services were
probed in detail.
All interviews were carried out by local interviewers in Swahili
and digitally recorded, transcribed and then translated into
English for analysis. Transcripts were read repeatedly specifically
to identify emerging taxonomies and themes. A coding scheme
was derived based initially on findings from a literature review and
exploratory focus group discussions, and refined based on themes
emerging in the interviews. Following the initial analysis, matrices
were created in Excel to allow cross-group comparisons between
women displaying different attendance patterns at HIV-related
services. Continuous and iterative hypothesis generation and
testing throughout the analysis allowed for continual refinement of
themes and ensured that the insights provided by the data could be
captured.
Linking Pregnant Women to HIV Care and Treatment
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Qualitative data were managed using NVivo Version 8 (QSR
International Pty Ltd. 2008).
Results
Cohort Study Enrolment
Figure 1 shows the flow of participants in the cohort.
During the study timeframe, 110 women in Naivasha Hospital
were eligible for study participation of whom 105 (95%) were
invited to participate. The other five women received their HIV
diagnosis on days when no research staff were at the hospital. All
women invited to participate in the study consented to take part.
Five women were excluded at the time of follow-up because
quantitative analyses on HIV clinic attendance were based on
health facility records and they reported having attended an HIV
clinic that was too far away for the study team to access their
records.
Of the 100 women in the cohort, 66 (66%) completed a
structured follow-up questionnaire: 18 in person and 48 by
telephone. Median time between enrolment and follow-up was
96.5 days (inter-quartile range (IQR): 93–110 days). No follow-up
information was available for 18 (18%) women and a further 16
(16%) could not be reached by telephone or in person even though
they had registered at an HIV clinic and their HIV clinic records
were accessed. There were no significant differences in the
baseline characteristics of women completing the follow-up
questionnaire versus those who could not be reached, including
HIV-related symptoms, distance from home to the hospital, and
prior contact with people living with HIV (see Table S1).
Cohort Participant Characteristics
Among 100 women enrolled in the cohort, the median age at
enrolment was 26 years (IQR: 23–30) and the majority of women
were married (Table 1). Most women had no more than primary
education and just over half were in paid employment. The
median gestational age at time of HIV diagnosis was 28 weeks.
Women reported a median travel time of 35 minutes (IQR: 30, 60)
to reach the hospital from their home, and 58% reported having to
pay for transport.
Qualitative Sub-study Participant Characteristics
The 19 women who participated in the qualitative sub-study
were more likely than the 81 who did not to have started attending
ANC before 28 weeks gestation (75% vs. 26%; p= 0.001), more
likely to have registered at the HIV clinic within 90 days of their
HIV diagnosis (74% vs. 48%; p= 0.045), and more likely to have
returned to the HIV clinic for a second visit (58% vs. 33%;
p= 0.047).
Client Attrition between Testing HIV-positive and
Attending HIV-related Services
Figure 2, based on health facility records, shows client attrition
along the pathway to HIV care and treatment services within 90
days of diagnosis with HIV. If no health facility record could be
found, it was assumed that the participant had not enrolled in HIV
care and treatment.
Client attrition was substantial at each step of this pathway: 47/
100 (47%) women were lost between diagnosis and registration at
an HIV clinic; a further 26/53 (49%) of those registering at the
HIV clinic did not have a CD4 count result in their file. Only 27 of
the original 100 women (27%) had a CD4 count result. Among 11
Figure 1. Cohort recruitment and follow-up.
doi:10.1371/journal.pone.0089764.g001
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Table 1. Factors Associated With Attendance At The HIV Clinic Within 90 Days Of HIV Diagnosis Among Women Diagnosed With
HIV In Pregnancy-Related Services.
Description N Attended HIV clinic (row %) UnAdjOR* 95%CI AdjOR* 95%CI
Age P= 0.980
15–19 8 4 (50.0) 0.88 0.18, 4.17
20–24 30 16 (53.3) 1.00
25–29 35 20 (57.1) 1.17 0.44, 3.11
30–44 27 15 (55.6) 1.09 0.38, 3.11
Education P= 0.521
None 2 1 (50.0) 0.72 0.04, 12.08
Some primary 62 36 (58.1) 1.00
Some secondary 29 16 (55.2) 0.89 0.37, 2.16
Post-secondary 7 2(28.6) 0.29 0.05, 1.61
Marital status P= 0.283
Not married (single/widowed/separated) 28 13 (46.4) 1.00
Married 72 42 (58.3) 1.62 0.67, 3.89
Employment P= 0.746
Unemployed 44 25 (56.8) 1.00
Employed 56 30 (53.6) 0.88 0.40, 1.94
Gravidity P= 0.554
One 29 15 (51.7) 1.00
Two 22 12 (54.5) 1.12 0.37, 3.40
Three 31 20 (64.5) 1.70 0.60, 4.78
Four+ 18 8 (44.4) 0.75 0.23, 2.43
Timing of 1st ANC P= 0.775
8–21 weeks 13 7 (53.8) 1.00
22–27 weeks 8 6 (75.0) 2.57 0.37, 17.83
28–34 weeks 31 20 (64.5) 1.56 0.42, 5.81
35–39 weeks 7 4 (57.1) 1.14 0.18, 7.28
Timing of HIV diagnosis P= 0.688
#28 weeks gestation (ANC) 63 34 (54.0) 1.00
29+ weeks gestation (ANC) 30 18 (60.0) 1.28 0.53, 3.09
Delivery 7 3 (42.3) 0.64 0.13, 3.10
Location of HIV diagnosis P= 0.788
ANC 91 50 (54.9) 1.00
Delivery 8 4 (50.0) 0.82 0.29, 3.48
Travel time from home to clinic P= 0.583
60+ minutes 24 12 (50.0) 1.00
,60 minutes 76 43 (56.6) 1.25 0.56, 2.78
Cost of travel to HIV clinic P= 0.015 P = 0.032
Not having to pay a transport fare1 58 26 (44.8) 1.00 1.00
Having to pay a fare 42 29 (69.0) 2.75 1.19, 6.32 2.73 1.09, 6.84
HIV symptoms2 P= 0.039 P = 0.202
None 60 28 (46.7) 1.00 1.00
At least one 40 27 (67.5) 2.37 1.03, 5.46 1.83 0.72, 4.62
Ever seen anyone with HIV P= 0.125
No 16 6 (37.5) 1.00
Yes 84 49 (58.3) 2.33 0.78, 7.02
Personally know anyone with HIV P= 0.089
No 31 13 (41.9) 1.00
Yes 68 41 (60.3) 2.10 0.89, 4.98
Personally know anyone who died of AIDS P= 0.037 P = 0.216
Linking Pregnant Women to HIV Care and Treatment
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ART-eligible women, a further 5 (45%) were lost between
receiving their CD4 count and actually starting ART. Overall,
only six women started ART (15% of the 41 women estimated as
likely to have been ART-eligible).
Delays Along the Pathway to HIV Care and Treatment
Among the 53 women who had registered at an HIV clinic
during the 90-day follow-up period, 32 (60%) registered on the day
of their HIV diagnosis of whom 12 (38%) did not return to the
HIV clinic again during the follow-up period. The median time to
registration at the HIV clinic among the remaining women who
registered at the HIV clinic within 90 days was 21 days (IQR: 11–
63).
The median time between registration and having blood taken
for a CD4 count was six days (IQR: 0–17). For ART-eligible
women, the median time between this blood-draw and initiating
ART was 28 days (IQR: 0–37), and the median number of
appointments between the visit at which they received their CD4
count result and being started on ART was two (Range: 0–5).
Among ART-eligible women who successfully started ART within
the 90-day follow-up period, the median time between diagnosis
and initiating ART was 48.5 days (IQR: 32–76).
Factors Associated with Uptake of HIV-related Services
Table 1 shows baseline factors associated with HIV clinic
registration within 90 days of diagnosis among the 100 women in
the cohort. As with Figure 2, this is based on health facility
records. In the univariable analysis these factors were: having
cared for someone with HIV (OR: 3.73; 95%CI: 1.34, 10.36;
p = 0.008), having to pay for transport to the hospital (OR: 2.75;
95%CI: 1.19, 6.32; p= 0.015), personally knowing someone who
died of AIDS (OR: 3.24; 95%CI: 1.03, 10.15; p= 0.037), and
having experienced at least one HIV-related symptom in the six
months prior to enrolment (OR: 2.37; 95%CI: 1.03, 5.46;
p = 0.039). There was also weak evidence of an association with
reporting having received enough information to decide to have
an HIV test (OR: 3.13; 95%CI: 0.89, 10.94; p = 0.064) and with
personally knowing someone with HIV (OR: 2.10; 95%CI: 0.89,
4.98; p = 0.089).
In the multivariable model, factors remaining independently
associated with the outcome were: having cared for someone with
HIV (aOR:3.67; 95%CI: 1.22, 11.09; p = 0.021) and having to
pay for transport to the hospital (aOR:2.73; 95%CI: 1.09, 6.32;
p = 0.032). There was also weak evidence of an independent
association between the outcome and having received enough
information to decide to have an HIV test (aOR:3.61; 95%CI:
0.83, 15.71; p = 0.087).
In the follow-up questionnaire administered to 66 women, 18
(27%) reported not having registered at an HIV clinic. The three
most commonly cited reasons for not having registered at an HIV
clinic were: women not knowing that they had to register (4/18;
22%), not having had time to register (3/18; 17%), and not feeling
ready to do so (2/18; 11%).
Of the 53 women who delivered during the study period and
had registered at the HIV clinic, 15 (28%) stopped attending the
HIV clinic for at least eight weeks around the time of delivery.
Qualitative Exploration of Reasons Underlying Women’s
Decisions Regarding Accessing HIV-related Services
The semi-structured interviews corroborated many of the
quantitative findings presented above. Three main areas were
reported to have affected women’s uptake of HIV services for their
own care: social support, interactions with health workers and
health services-related factors.
Table 1. Cont.
Description N Attended HIV clinic (row %) UnAdjOR* 95%CI AdjOR* 95%CI
No 16 5 (31.3) 1.00 1.00
Yes 84 50 (59.5) 3.24 1.03, 10.15 2.21 0.63, 7.80
Ever cared for anyone with HIV P= 0.008 P = 0.021
No 72 34 (47.2) 1.00 1.00
Yes 26 20 (76.9) 3.73 1.34, 10.36 3.67 1.22, 11.09
Enough information to decide whether or not to test3 P = 0.064 P = 0.087
No 13 4 (30.8) 1.00 1.00
Yes 86 50 (58.1) 3.13 0.89, 10.94 3.61 0.83, 15.71
Self-perceived ability to refuse to test P= 0.710
No 62 35 (56.5) 1.00
Yes 38 20 (52.6) 0.86 0.38, 1.93
Receipt of PMTCT prophylaxis P= 0.245
Maternal and infant 45 23 (51.1) 1.00
Maternal only 15 6 (40.0) 0.64 0.19, 2.09
Infant only 31 19 (61.3) 1.51 0.60, 3.84
No prophylaxis 9 7 (77.8) 3.35 0.63, 17.90
*P-values relate to heterogeneity from a likelihood ratio test.
1Participants who did not have to pay for transport walked to the hospital.
2Participants were asked if they had experienced any of the following symptoms within the previous six months: diarrhoea; big problems with memory or concentration
that interfered with normal activities; cough for more than two weeks; high fever; swollen glands; a yeast infection in the mouth or vagina (thrush); numbness, tingling
or burning sensations in the arms, legs, hands or feet; substantial weight loss; or a skin rash.
3Within a series of questions regarding pre-test counselling, women were asked ‘‘Did you feel that you were given enough information to decide whether or not to have
an HIV test?’’.
doi:10.1371/journal.pone.0089764.t001
Linking Pregnant Women to HIV Care and Treatment
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e89764
Social support. Supportive partners, family and friends
facilitated uptake of care by helping around the house, reminding
women to take their drugs and providing emotional support:
‘‘[My husband] tells me that I shouldn’t stress myself…. [He says] ‘Stop
stressing yourself… there are people who love you’.’’ (Participant #126,
Age 31).
Conversely, many women reported that following disclosure to
their partner they had never again discussed their HIV status with
him or any other friend or family member, primarily because they
perceived a lack of willingness to talk about their HIV status with
them. As one woman explained:
‘‘I went to test. [After the test]… I made a phone call to my husband. He
told me that it is my problem. He said he doesn’t have [HIV]… I told him and
he ran away, and when he came back he told me not to tell him that
information again.’’ (Participant #218, Age 21).
Some women reported that their husbands did not want them to
disclose their status to anyone else. This lack of communication
and low level of disclosure beyond partners left some women
feeling isolated as they struggled to come to terms with their HIV
diagnosis.
Women’s perceptions of HIV-related attitudes suggested that,
for most, the potential negative social consequences of disclosure
still outweighed perceived benefits, which contributed to low levels
of attendance at HIV clinics and support groups.
Interactions with health workers. Health workers might
be considered another potentially important source of support for
women with HIV. Yet many women described suboptimal
communications with health workers. In the context of HIV
counselling, many women reported feeling unprepared for being
tested:
‘‘I felt like she just ambushed me and tested me… people are supposed to be
given counselling… so that if [the test result] is positive… you won’t have to
worry a lot.’’ (Participant #228, Age 32).
In addition, many women reported being ‘‘talked to badly’’ by
reception staff at the HIV clinic, with some feeling ‘‘a little despised’’.
They found this particularly intimidating during early visits to the
HIV clinic and some women reported being afraid to attend the
clinic again if they had missed an appointment for fear of being
reprimanded.
Other instances where interactions with health workers
negatively affected uptake of services were also reported. One
woman travelled to her rural home for three months where the
HIV clinic refused to register her as she lived in Naivasha so she
only began attending services when she returned to Naivasha.
‘‘They said I couldn’t [attend the local HIV clinic]. I must be at a
permanent place because of my status… I was not from there so they said they
wouldn’t do a CD4 for me.’’ (Participant 116, Age 33).
Another participant was told not to start ART until she had
completed three months of treatment for tuberculosis, which she
duly did, even though this delay was contrary to national
guidelines for HIV treatment initiation.
In several cases, a sudden change in HIV clinic attendance
patterns – from regular attendance at scheduled appointments to
non-attendance – came immediately following a negative experi-
ence within the hospital. One woman, for example, dropped out of
care when she was asked to repeat (and re-pay for) her CD4 count
test as her result had been lost. Another woman stopped attending
Figure 2. Client attrition along the pathway to long-term HIV care and treatment services.
doi:10.1371/journal.pone.0089764.g002
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following a miscarriage. In addition to associating her miscarriage
with having started ART a week before it occurred, she described
staff refusal to attend to her during the stillbirth. At the time of the
interview, she had not been to the HIV clinic for five months,
meaning that she was not receiving cotrimoxazole as recommend-
ed.
Conversely, one woman began attending HIV services months
after her HIV diagnosis based on a positive interaction with a
health worker: she had attempted to abandon her baby and
commit suicide but she was caught, arrested, and taken to the
hospital where she reported having received great support and
encouragement through counselling from the hospital matron.
Health services-related factors. Reflecting the quantitative
findings, costs, including transport costs, were frequently men-
tioned as a barrier to hospital attendance.
‘‘I lacked money to start on ARVs because I was told that I had to have
250 shillings ($2.87) to begin the clinic. It took me time because everyone had
deserted me… my neighbours, husband… I had no friends and no money. So it
forced me to sell my baby’s blanket so that I could afford to start the clinic.’’
(Participant #215, Age 22).
Many women reported that they had delayed or not had a CD4
count blood-draw due to its cost (usually approximately KShs170
($1.95)). Conversely, antiretrovirals being free proved a very strong
motivational factor for many women to attend HIV services.
Women described difficulties navigating the pathway between
HIV testing in pregnancy-related services and long-term HIV care
and treatment. Women described having to visit multiple
departments in a single day with long waiting times and having
to visit the hospital on many different days:
‘‘They make you wait the whole day and make you come here another time
for something else, it is not good.’’ (Participant #115, Age 20).
Additional challenges included difficulty in understanding
directions, poor understanding of the patient pathway and
restricted clinic hours.
Discussion
A lower proportion (53%) of women diagnosed with HIV in
pregnancy in this cohort registered at the HIV clinic than in
previously published studies (62–85%) from elsewhere in sub-
Saharan Africa, [9–12] although this might be partially explained
by this study’s relatively short follow-up period. The higher
proportion of women registering at an HIV clinic in this study
compared to the retrospective study we carried out in Naivasha
Hospital can be largely attributed to improvements in attendance
over time and the ability of the prospective cohort to capture
women’s attendance at a range of HIV clinics outside Naivasha
Hospital.
The uptake of ART among known-eligible women diagnosed
with HIV in pregnancy-related services reported in previous
studies in sub-Saharan Africa has varied enormously (12–95%).
[9,10,12–19] A recent meta-analysis that included both observa-
tional and intervention studies estimated that 68% of women
diagnosed with HIV in pregnancy had a CD4 cell count done and
that 61% of the women who were eligible for ART started
treatment. [20] Due to attrition at each step along the pathway to
treatment, our study found low uptake of ART in comparison to
many other studies. [4] The scale of and reasons underlying
attrition from long-term HIV care and treatment services around
the time of delivery warrant further study in larger studies.
The qualitative finding that lack of social support impeded
uptake of long-term HIV care and treatment services echoes
previous studies that have found higher levels of social support to
facilitate uptake of PMTCT services and adherence to ART.
[21,22] Although nurse escorts to the HIV clinic at Naivasha
Hospital might have increased registration at this clinic immedi-
ately following diagnosis with HIV in pregnancy-related services,
the high proportion of women who never returned for a
subsequent visit to the HIV clinic suggests the need for on-going
support for women to ensure uptake of CD4 count testing as well
as on-going care and treatment services. The association between
having cared for someone living with HIV and successful linkage
to the HIV clinic is a new finding. Previous studies have shown
close personal contact with someone with HIV to be associated
with changes in HIV-related risk behaviours, [23,24] but this has
not previously been explored with regard to uptake of HIV care
and treatment services.
Although an insufficient measure for informed choice, the weak
association between women reporting having received enough
information to decide whether or not to take an HIV test and
registering at an HIV clinic suggests that current counselling in
some settings may be insufficient for preparing pregnant women
for a potential HIV diagnosis, with implications for their
subsequent uptake of care. A study in Uganda found that some
women perceive provider-initiated HIV testing and counselling
within antenatal care as compulsory and they do not fully
understand its potential consequences, [25] but this remains an
underexplored area.
Finally, this study confirms previous studies’ findings that
complicated patient pathways, [11,26,27] low knowledge among
clients of the need to attend the HIV clinic, [27] transportation
costs, [28–33] and negative experiences in health facilities may
adversely affect future uptake of services. [28,34,35].
Limitations
Limitations of this study include its relatively small sample size.
We may have over-estimated client losses if some of the 18 women
with no follow-up information accessed HIV care outside the study
area. On the other hand, observation showed that the hospital’s
policy that a nurse from the ANC should accompany any HIV-
positive woman to the HIV clinic was not always followed so
researchers escorting women to the HIV clinic will have improved
their initial linkage into care.
The difficulty arranging qualitative interviews with women who
had poorer hospital attendance meant that interview participants
under-represented this group. Women’s primary reason for
refusing to be interviewed was that they had travelled to rural
areas and would not return for weeks or months, which would
equally have impeded their hospital attendance.
Conclusions and Recommendations
Only 15% of women estimated to be ART-eligible in this cohort
started ART within 90 days of their HIV diagnosis. Recommen-
dations for increasing uptake of long-term HIV care and treatment
services include: appropriate counselling that allows sufficient time
and information for women to make informed decisions about if
and when to use services; simplifying the pathway to care by
reducing the required number of visits and increasing accessibility
of CD4 testing, ideally using point-of-care CD4 testing; ensuring
the daily availability of ART services within ANC (this is being
promoted by the Kenyan government and the WHO); [8,36]
ensuring adequate staffing within ANC, delivery and the HIV
clinic; linking women to the HIV clinic post-delivery; and
improving the quality of interactions between health workers
and clients.
The benefits to an individual of timely access to care, coupled
with the increased costs to the health system incurred through
delayed access, draw attention to the need to address the factors
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identified as impediments to prompt linkage into HIV care and
treatment services.
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